Article Information
PubMed
Published By
Print ISSN
Online ISSN
History
- Received for publication April 17, 2006
- Accepted for publication September 6, 2006
- Published online November 30, 2006.
Copyright & Usage
© 2006 by Society of Nuclear Medicine
Author Information
- Wei-Ann Hsueh 1 ,
- Amanda L. Kesner 1 ,
- Anne Gangloff 1 ,
- Mark D. Pegram 2 ,
- Malgorzata Beryt 2 ,
- Johannes Czernin 1 ,
- Michael E. Phelps 1 and
- Daniel H.S. Silverman 1
- 1Ahmanson Biological Imaging Division, Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, University of California, Los Angeles, California; and 2Divison of Hematology and Oncology, Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, California
- For correspondence or reprints contact: Daniel H.S. Silverman, MD, PhD, CHS AR-144, Nuclear Medicine Clinic, MC694215, UCLA Medical Center, Los Angeles, CA 90095-6942. E-mail: dsilver{at}ucla.edu Guest Editor: Norbert Avril, St. Bartholomew's Hospital
Statistics from Altmetric.com
Cited By...
Article usage
Jump to section
Related Articles
Cited By...
- 64Cu-MM-302 Positron Emission Tomography Quantifies Variability of Enhanced Permeability and Retention of Nanoparticles in Relation to Treatment Response in Patients with Metastatic Breast Cancer
- In Vivo Imaging as a Pharmacodynamic Marker
- Human Dosimetry and Preliminary Tumor Distribution of 18F-Fluoropaclitaxel in Healthy Volunteers and Newly Diagnosed Breast Cancer Patients Using PET/CT
- The Role of Radiotracer Imaging in the Diagnosis and Management of Patients with Breast Cancer: Part 2--Response to Therapy, Other Indications, and Future Directions